Could a 12-Month break from prostate cancer drugs be enough?
Disease control
Recruiting now
This study tests whether men with low-volume metastatic prostate cancer can safely stop taking certain hormone drugs (apalutamide or enzalutamide) after 12 months, instead of continuing indefinitely. 400 men will be randomly assigned to either stop or continue therapy, with the o…
Phase: PHASE3 • Sponsor: Nick Beije • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC